C3898673_NCI_CareLex | Knowledge4COVID-19

Property	Value
?:definition	Documentation tracking the transfer of investigational product (IP) between depots and sites (within or across protocols). This may include, but is not limited to, sponsor approval for transfer and evidence of consultation with a Qualified Person (QP), where required. [Adapted from TMF-RM]
?:hasCUIAnnotation	<https://research.tib.eu/covid-19/entity/C3898673>
?:hasGeneratedBy	<https://research.tib.eu/covid-19/SourceName/NCI_CareLex>
?:type	<https://research.tib.eu/covid-19/vocab/AnnotationDefinition>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/C3898673_NCI_CareLex>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/C3898673_NCI_CareLex>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all